Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
   Class I cytokine receptors (hematopoietin family receptors)
   Class II cytokine receptors (interferon/IL-10 family receptors)
   Receptor tyrosine kinase
     RTK class I (EGF receptor family)
     RTK class II (Insulin receptor family)
       insulin receptor [HSA:3643] [KO:K04527]
       insulin-like growth factor 1 receptor [HSA:3480] [KO:K05087]
         Mecasermin
           D03297  Mecasermin (genetical recombination) (JAN); Mecasermin (USAN/INN)
Agonist
         Mecasermin rinfabate
         Cixutumumab
         Dalotuzumab
         Figitumumab
         Ganitumab
         Linsitinib
         Robatumumab
     RTK class III (PDGF receptor family)
     RTK class IV (FGF receptor family)
     RTK class V (VEGF receptor family)
     RTK class VI (HGF receptor family)
     RTK class VIII (EPH receptor family)
     RTK class X (LTK receptor family)
     RTK class XIV (RET receptor family)
   TNF receptor family
   IL-1 receptor family
   IL-17 receptor family
   TGF-beta receptors
   Chemokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 22, 2014

» Japanese version